Hereditary motor and sensory neuropathy with pyramidal features is a very rare nerve disease that runs in families. It affects the long nerves that move the muscles (motor nerves) and the nerves that carry feeling (sensory nerves). It also affects the “pyramidal” pathways in the brain and spinal cord that control movement and reflexes. Doctors often group it inside the Charcot-Marie-Tooth (CMT) diseases and call it Charcot-Marie-Tooth disease type 5 (CMT5). In this condition, people usually have weakness and wasting in the lower legs and feet, high foot arches, and changes in feeling, together with brisk reflexes and other pyramidal signs, but often without very stiff, spastic walking. MalaCards+3Genetic and Rare Diseases Center+3National Organization for Rare Disorders+3
Hereditary motor and sensory neuropathy with pyramidal features is a rare genetic nerve disease. It sits inside the Charcot-Marie-Tooth (CMT) group, especially CMT type 5, and is sometimes called hereditary motor and sensory neuropathy type 5 (HMSN V). In this condition, long nerves to the feet, legs, hands and arms slowly become weak and thin, so muscles at the ends of the limbs slowly waste and become weak. Pyramidal features mean there are also signs from the “pyramidal tracts” in the brain and spinal cord, such as brisk reflexes, Babinski sign and mild stiffness or spasticity. Walking becomes difficult, there may be foot drop and high-arched feet, and some people feel cramps or pain. The disease usually progresses slowly over years, and there is no cure yet, so treatment focuses on staying mobile, preventing deformity and managing pain and spasticity. Cleveland Clinic+4Genetic and Rare Diseases Center+4Orpha.net+4
Other names
Doctors and researchers have used many different names for this same disease. All of the names below describe the same or very closely related conditions in medical papers:
-
Charcot-Marie-Tooth disease type 5
-
Charcot-Marie-Tooth neuropathy with pyramidal features
-
Charcot-Marie-Tooth disease-pyramidal features syndrome
-
Hereditary motor and sensory neuropathy type 5 (HMSN type V)
-
Hereditary motor and sensory neuropathy with pyramidal features
-
Hereditary sensory-motor neuropathy type V
-
Peroneal muscular atrophy with pyramidal features
-
Axonal Charcot-Marie-Tooth disease with pyramidal signs
These names reflect that the main problem is hereditary (runs in families), affects both motor and sensory nerves, and has extra “pyramidal” signs, such as very brisk reflexes and an up-going big toe when the sole is stroked. Thieme Connect+3MalaCards+3 Mouse Genome Informatics+3
Types
There is no simple “official” type list that every doctor uses, but in practice doctors think about several patterns. These patterns are based on which gene is changed and how the person looks clinically.
-
Classic HMSN type V / CMT type 5
In this pattern, people have weakness and wasting mainly in the lower legs and feet, high arches, and difficulty walking. They also have pyramidal signs such as brisk knee reflexes or an up-going big toe, but often do not have very stiff legs. This group is usually inherited in an autosomal dominant way, meaning one changed gene from one parent is enough to cause disease. Thieme Connect+1 -
Axonal CMT with pyramidal signs (KIF5A-related)
Some people have changes in the KIF5A gene, which makes a motor protein that carries cargo inside nerve cells. They show an “axonal” pattern of neuropathy (damage to the long part of the nerve) and pyramidal signs such as brisk reflexes or mild spasticity. This pattern overlaps with hereditary spastic paraplegia and CMT2 with pyramidal signs. Taylor & Francis Online+2Springer Link+2 -
BSCL2-related neuropathy / Silver syndrome spectrum
Mutations in the BSCL2 gene (also called seipinopathy) can cause distal hereditary motor neuropathy type V and Silver syndrome. People may have very thin and weak hand muscles and spasticity in the legs. The same gene change can therefore cause a mixed picture of motor neuropathy and pyramidal features, fitting into the HMSN with pyramidal features group. NCBI+2PubMed+2 -
EGR2-related CMT with pyramidal features
In some families, a new change (mutation) in the EGR2 gene has been found. People have childhood-onset peripheral neuropathy with weakness and foot deformities, plus pyramidal signs such as brisk reflexes. This also sits inside the “CMT with pyramidal features” category. PMC+1 -
MORC2 and other gene-related forms with pyramidal signs
MORC2 mutations can cause axonal CMT with pyramidal signs and sometimes other central nervous system changes. Many other CMT genes can rarely show pyramidal features, so doctors now talk about a spectrum, not just one single form. MDPI+3PMC+3Frontiers+3
Causes
All true root causes are genetic. The extra “causes” below break down the genetics and the different ways the genes can lead to nerve damage and pyramidal signs.
-
Pathogenic KIF5A gene mutations
Changes in the KIF5A gene can disturb a motor protein that moves materials along microtubules in nerve cells. When this transport system fails, long motor and sensory nerves degenerate. This can give axonal neuropathy and pyramidal signs, forming a picture like hereditary motor and sensory neuropathy with pyramidal features. Taylor & Francis Online+2PMC+2 -
Pathogenic BSCL2 (seipin) gene mutations
BSCL2 mutations can cause distal hereditary motor neuropathy type V and Silver syndrome. The mutant seipin protein can misfold, stress the endoplasmic reticulum, and damage motor neurons in the spinal cord. This leads to weakness in hands and legs plus spasticity and brisk reflexes. NCBI+2PubMed+2 -
MFN2 gene mutations with pyramidal involvement
MFN2 mutations normally cause CMT2A, an axonal CMT. In some families, there is extra involvement of central motor pathways, producing pyramidal signs. This creates a combined motor and sensory neuropathy with pyramidal features similar to CMT5. PubMed+2ScienceDirect+2 -
EGR2 gene mutations
The EGR2 gene helps control myelin formation in peripheral nerves. Some EGR2 mutations cause CMT with pyramidal signs, so both the myelin around nerves and the central motor pathways are affected, leading to a mixed peripheral and pyramidal picture. PMC+2Mattioli 1885+2 -
MORC2 gene mutations
MORC2 mutations are now known to cause axonal CMT with pyramidal signs. Patients can show neuropathy plus signs of brain or spinal cord involvement, such as spastic legs or brisk reflexes, fitting into the hereditary neuropathy with pyramidal features spectrum. PMC+2Frontiers+2 -
Other CMT gene mutations with pyramidal signs
Studies of CMT cohorts show that several less common CMT genes can sometimes produce pyramidal signs in addition to neuropathy. This means that different gene mutations can converge on a similar clinical picture of hereditary motor and sensory neuropathy with pyramidal features. PMC+2Frontiers+2 -
Autosomal dominant inheritance pattern
Most reported families show autosomal dominant inheritance. This means one changed copy of the gene from one parent is enough to cause disease. Many affected people have an affected parent and several affected relatives over generations. Thieme Connect+2Monarch Initiative+2 -
Autosomal recessive axonal CMT with pyramidal features
Some rare forms of axonal CMT with pyramidal features follow an autosomal recessive pattern. In these families, a person needs two changed copies of a gene (one from each parent) to show disease. Parents may be healthy carriers, but children can have the full syndrome. MalaCards+2Monarch Initiative+2 -
Genetic heterogeneity (many possible genes)
Research has shown that “CMT with pyramidal signs” is genetically heterogeneous. Different families can have different genes involved (for example MFN2, KIF5A, BSCL2, EGR2, MORC2). This is why genetic panel testing is often needed instead of looking for only one gene. PubMed+2PMC+2 -
Axonal degeneration of motor nerves
Regardless of the exact gene, many forms show axonal degeneration of long motor nerves to the legs and feet. The axons slowly thin and die back, leading to muscle weakness, wasting, and foot deformities that are typical of CMT and HMSN. National Organization for Rare Disorders+2PMC+2 -
Axonal degeneration of sensory nerves
Sensory nerve fibers that carry touch, pain, temperature, and position sense can also degenerate. This damage leads to numbness, tingling, loss of vibration sense, and poor balance in the dark. These sensory changes are part of the “sensory” part in hereditary motor and sensory neuropathy. National Organization for Rare Disorders+2ScienceDirect+2 -
Pyramidal tract involvement in the spinal cord
The pyramidal tracts run from the brain down the spinal cord and control movement and reflexes. In this disease group, these tracts are partly damaged or over-excitable. This leads to brisk reflexes, an up-going big toe, and sometimes mild stiffness, even though the main damage is in the peripheral nerves. Monarch Initiative+2ResearchGate+2 -
Abnormal intracellular transport in neurons
Genes like KIF5A encode motor proteins that carry organelles and other cargo inside neurons. When these motors do not work properly, the long axons cannot get enough energy and building blocks. Over time, this lack leads to axon damage and combined neuropathy plus pyramidal signs. Taylor & Francis Online+2PMC+2 -
Mitochondrial dysfunction in axons
MFN2 and some related genes help maintain healthy mitochondria, the “power plants” of the cell. Mutations can damage mitochondrial function and transport, especially in long axons, so nerves cannot produce enough energy. This contributes to slowly progressive neuropathy and sometimes central motor tract problems. MalaCards+2ScienceDirect+2 -
Endoplasmic reticulum stress and protein misfolding
BSCL2-related disorders show that misfolded seipin accumulates in the endoplasmic reticulum and stresses cells. This stress can lead to death of motor neurons in the spinal cord and degeneration of corticospinal (pyramidal) pathways, explaining both hand muscle wasting and spastic legs. Springer Link+2NCBI+2 -
Developmental vulnerability of long nerves
Very long nerves to the legs and feet are more vulnerable to small problems in axonal transport or myelin. Even mild gene changes can first affect these long nerves, so symptoms start in the feet in childhood or early adult life, then slowly move upward. PMC+2National Organization for Rare Disorders+2 -
Modifier genes and genetic background
The same main mutation can give different severity in different people. This suggests that other genes in the background can modify how bad the disease becomes, and whether pyramidal signs appear. These modifier effects are seen in many CMT families. Merck Millipore+2Frontiers+2 -
De novo (new) mutations
In some cases, the mutation may appear for the first time in the affected person and is not found in either parent. This is called a de novo mutation. The cause is a random change in the DNA in the egg or sperm, not anything the parents did. PMC+2PMC+2 -
Combination of peripheral neuropathy and central involvement
Some genes are mainly known for hereditary spastic paraplegia and others for CMT. When the same gene affects both peripheral nerves and central motor tracts together, the person shows a combined phenotype that fits “HMSN with pyramidal features.” ResearchGate+2Taylor & Francis Online+2 -
Unknown genetic defects (yet to be found)
Even with modern gene panels, some families with clear hereditary motor and sensory neuropathy and pyramidal signs have no known mutation found. This means other genes or more complex genetic mechanisms are still waiting to be discovered. PMC+2PMC+2
Symptoms
-
Slowly progressive weakness in the feet and lower legs
Many people first notice that their feet feel weak. They trip over small objects or their toes catch the ground. Over years, the weakness spreads slowly up the legs. This weakness comes from damage to the motor nerves that supply the leg muscles. National Organization for Rare Disorders+2Nepal Journals Online+2 -
Muscle wasting in the lower legs (“inverted champagne bottle” legs)
Because the muscles are weak and poorly supplied by nerves, they shrink over time. The lower legs below the knees look thin, while the thighs may look normal. This typical shape is often seen in many CMT and HMSN patients. ResearchGate+2ScienceDirect+2 -
High arches and claw toes (foot deformities)
The imbalance between weak and stronger muscles around the foot creates high arches (pes cavus) and curled toes (claw toes). These deformities make shoes uncomfortable and worsen tripping. They are common in CMT with pyramidal features. ResearchGate+2Nepal Journals Online+2 -
Difficulty running and walking long distances
Because of weakness and foot deformities, running becomes hard early in the disease. Longer walks cause fatigue, pain, or frequent tripping. People may choose flat, supportive shoes and avoid rough ground. Nepal Journals Online+2PMC+2 -
Numbness and reduced feeling in the feet
Damage to sensory nerves leads to numbness, tingling, or “cotton wool” feeling in the feet. People may not feel small injuries or changes in temperature, which can increase the risk of unnoticed wounds. National Organization for Rare Disorders+2ScienceDirect+2 -
Loss of vibration and position sense
The ability to feel vibration (for example, from a tuning fork) and to know where the toes are in space can be reduced. This makes balance worse, especially in the dark when the eyes cannot help. PMC+2ScienceDirect+2 -
Balance problems and unsteady walking
Because of weakness and loss of position sense, people may feel unsteady and sway when standing, particularly with eyes closed. Walking on uneven ground or in dim light can be difficult, and falls may occur. PMC+2Nepal Journals Online+2 -
Hand weakness (in some subtypes)
In BSCL2-related and some other forms, small hand muscles become thin and weak. People may have trouble with buttons, handwriting, or holding small objects. This is more marked in Silver syndrome-type presentations. NCBI+2PubMed+2 -
Brisk tendon reflexes (pyramidal sign)
A key feature is very brisk knee and ankle reflexes when the doctor taps the tendon. This is unusual in ordinary CMT, where reflexes are often lost, so brisk reflexes point to added pyramidal involvement. Monarch Initiative+2ResearchGate+2 -
Up-going big toe on plantar reflex (Babinski sign)
When the sole of the foot is stroked, the big toe may go upward instead of downward. This Babinski sign is a classic pyramidal sign and shows that the central motor pathways in the brain and spinal cord are affected. Monarch Initiative+2ResearchGate+2 -
Mild stiffness or spasticity in the legs
Some people feel their legs are stiff, especially after rest. They may have difficulty starting to walk or feel their legs are “tight.” This spasticity is usually mild compared with pure hereditary spastic paraplegia, but it is another pyramidal feature. Thieme Connect+2ResearchGate+2 -
Foot drop
Weakness of the muscles that lift the foot leads to “foot drop.” The toes drag on the ground unless the person lifts the knee higher than normal. Family and friends may notice this steppage gait before the patient does. Nepal Journals Online+2PMC+2 -
Fatigue and muscle cramps
Long-lasting nerve damage and abnormal gait can cause fatigue and muscle cramps in the legs and sometimes in the hands. People may feel tired after everyday tasks and need more rest than before. ScienceDirect+2Clinical Tree+2 -
Slow progression over many years
Symptoms usually appear in childhood, teenage years, or early adult life, then progress slowly. Many people remain able to walk but may need shoe inserts, braces, or sometimes a walking aid later in life. National Organization for Rare Disorders+2Thieme Connect+2 -
Normal or mildly changed thinking and senses like vision and hearing (usually)
In most people, thinking ability, vision, and hearing stay normal, because the main problem is in motor and sensory nerves and some motor pathways. In a few rare gene types, other brain areas can be involved, but that is less typical of classic HMSN with pyramidal features. PMC+2GeneCards+2
Diagnostic tests
Doctors use a combination of clinical examination and tests to confirm the diagnosis, rule out other diseases, and find the exact gene change. The tests can be grouped into physical examination, manual or bedside tests, laboratory and pathological tests, electrodiagnostic tests, and imaging tests. Clinical Tree+3PMC+3Nepal Journals Online+3
Physical examination tests
-
Neurological motor examination
The doctor checks muscle strength in the legs, feet, hands, and arms. They look for weakness, especially in ankle and toe movements, and compare both sides. They also observe muscle bulk to see if there is wasting in the lower legs and hands. This helps show the pattern of motor nerve damage. PMC+2ScienceDirect+2 -
Sensory examination
The doctor tests light touch, pinprick, vibration, and position sense, usually from toes upward. Reduced feeling in a “stocking” pattern suggests peripheral neuropathy. Loss of vibration and position sense supports sensory nerve involvement, which is typical in hereditary motor and sensory neuropathy. ScienceDirect+2PMC+2 -
Reflex testing
Deep tendon reflexes at the knees and ankles are checked with a reflex hammer. In classic CMT they may be reduced, but in HMSN with pyramidal features they can be normal or brisk. This unusual combination gives a strong clue that pyramidal tracts are involved along with peripheral nerves. Monarch Initiative+2ResearchGate+2 -
Plantar response (Babinski sign)
The doctor strokes the sole of the foot to see how the big toe moves. An up-going big toe shows a Babinski sign, which is a hallmark of pyramidal tract damage. Finding this together with signs of neuropathy points strongly toward this combined hereditary condition. Monarch Initiative+2ResearchGate+2 -
Gait and posture assessment
The doctor watches how the person walks, including heel-walking, toe-walking, and walking on a straight line. They may see foot drop, high stepping gait, instability, or mild stiffness. They also check standing balance with eyes open and closed. This helps measure functional impact of the neuropathy and pyramidal signs. PMC+2Nepal Journals Online+2
Manual and bedside tests
-
Manual muscle testing
Using hands, the examiner pushes against different joints while the patient tries to resist. They grade strength on a simple scale. This bedside test shows which muscle groups are weak and helps track changes over time without special machines. PMC+1 -
Functional tests (timed walking, stair climbing)
Simple timed tests, such as how long it takes to walk 10 meters or climb a flight of stairs, give a clear picture of day-to-day function. Repeating these tests over time shows whether the disease is stable, slowly worsening, or responding to supportive treatment. Clinical Tree+1 -
Balance tests (Romberg test)
In the Romberg test, the patient stands with feet together and then closes their eyes. Increased swaying or falling suggests problems with position sense or balance pathways. This is common in sensory neuropathy and helps explain falls and unsteadiness. PMC+1 -
Foot and hand function tests
Doctors may ask the person to grip a dynamometer, write, button up clothing, or pick up small objects. These simple tasks show the real-life effect of muscle weakness and hand involvement, especially in BSCL2-related forms. NCBI+1
Lab and pathological tests
-
Basic blood tests to exclude other causes
Blood tests such as blood sugar, vitamin B12, thyroid levels, and kidney and liver tests help rule out common acquired causes of neuropathy, like diabetes or vitamin deficiency. Normal results support the idea of a hereditary cause instead. PMC+1 -
Genetic panel testing for CMT and hereditary neuropathies
Modern gene panels can test many CMT and hereditary neuropathy genes at once. They often include MFN2, KIF5A, BSCL2, EGR2, MORC2, and many others. Finding a clear disease-causing mutation confirms the diagnosis and helps with family counselling. PMC+2MalaCards+2 -
Targeted genetic testing for a known family mutation
If a mutation is already known in the family, other relatives can be tested for that specific change. This is easier, cheaper, and gives clear yes/no results. It also helps identify at-risk family members who may benefit from early monitoring. PMC+2GeneDX Providers+2 -
Whole exome or genome sequencing (in unsolved cases)
When panel testing is negative but the clinical picture strongly suggests hereditary neuropathy with pyramidal features, exome or genome sequencing may be used. These broad tests can find rare or new gene changes and help discover new disease genes. PMC+2Frontiers+2 -
Nerve or muscle biopsy (now less common)
In the past, doctors sometimes removed a small piece of nerve or muscle for study under the microscope. They looked for axonal loss, myelin changes, or other patterns. Today, biopsy is used less often because genetic testing has improved, but it may still be done when diagnosis remains unclear. PMC+2ScienceDirect+2
Electrodiagnostic tests
-
Nerve conduction studies (NCS)
In this test, small electric shocks are used to stimulate nerves, and the response is recorded. In HMSN with pyramidal features, conduction is often of “axonal” type, meaning reduced response size but relatively preserved speed. This pattern helps separate it from demyelinating forms of CMT. PMC+2PMC+2 -
Electromyography (EMG)
A thin needle is placed in muscles to record electrical activity. EMG in this disease shows signs of chronic denervation and re-innervation, meaning that nerves have been damaged and surviving nerves try to grow new branches. EMG confirms the presence of a neuropathic process. PMC+2PMC+2 -
Somatosensory evoked potentials (sometimes)
In some centers, doctors test how sensory signals travel from limbs to the brain. Delayed or reduced responses can show involvement of spinal cord pathways in addition to peripheral nerves, supporting the presence of pyramidal or central changes. PMC+2PMC+2
Imaging tests
-
MRI of the brain and spinal cord
MRI can look at the brain and spinal cord to rule out other causes of pyramidal signs, such as multiple sclerosis, stroke, or structural lesions. In many hereditary cases, MRI is normal or shows only subtle changes, but a normal scan helps confirm that the problem is mainly genetic and diffuse. PMC+2Frontiers+2 -
MRI of muscles (muscle imaging)
In some patients, MRI or ultrasound of muscles can show patterns of muscle wasting and fatty replacement. These patterns may help distinguish different neuropathies and track progression over time in research settings. PMC+2MDPI+2 -
Skeletal X-rays of feet and spine
Simple X-rays can show foot deformities like high arches, claw toes, or changes in joints due to long-term abnormal loading. They may also show curvature of the spine if present. This helps orthopedic planning for braces or surgery if needed. PMC+2Neuromuscular+2
Non-pharmacological treatments
Below are key non-drug treatments. They usually work best together in a long-term, personalized rehabilitation plan led by a neurologist, physiatrist (rehab doctor), physiotherapist, occupational therapist and orthotist. Charcot-Marie-Tooth Association+3NINDS+3Cleveland Clinic+3
-
Structured physical therapy and stretching
A physiotherapist designs a gentle program of strengthening, stretching and balance work. The purpose is to keep muscles as strong and flexible as possible and to protect joints from stiffness and contractures. Regular, low-to-moderate exercise helps maintain walking, reduces joint stress and may slow functional decline. The main mechanism is “use it but do not abuse it”: light, repeated movement keeps nerves and muscles active without over-fatiguing them. Cleveland Clinic+2Highlands Foot+2 -
Occupational therapy for hands and daily tasks
An occupational therapist teaches easier ways to dress, write, cook and use tools when hand weakness or clumsiness appears. The purpose is to keep independence at home, school and work. They may suggest grip aids, adapted pens, special cutlery and energy-saving tricks. The mechanism is to match the task to the patient’s strength and to use ergonomic tools so the same activity needs less force and better joint protection. NINDS+2Cleveland Clinic+2 -
Ankle-foot orthoses (AFOs) and other braces
AFOs are light plastic or carbon braces that hold the ankle at a safe angle when foot-drop is present. The purpose is to improve walking, reduce trips and falls, and protect joints. By stabilizing the ankle and controlling how the foot hits the ground, they reduce effort and energy cost when walking and can prevent long-term deformity. Cleveland Clinic+3Mayo Clinic+3Charcot-Marie-Tooth Disease+3 -
Custom footwear and insoles
Special shoes, boots or insoles support high arches, clawed toes and unstable ankles. The purpose is to spread pressure more evenly, prevent skin breakdown and make walking safer and more comfortable. The mechanism is simple biomechanics: better alignment and cushioning reduce abnormal stress on bones, joints and nerves. Mayo Clinic+2Cleveland Clinic+2 -
Walking aids (cane, crutches, walker, wheelchair for distance)
When balance or strength is poor, simple aids can prevent falls. The purpose is not to “give up” walking, but to extend safe walking distance and protect from injuries. Mechanically, an extra support point reduces load on weak muscles and shifts some weight through the arms or wheels. Cleveland Clinic+1 -
Targeted spasticity stretching program
Because pyramidal features cause increased tone, a daily stretching routine for calves, hamstrings, hip flexors and sometimes upper-limb muscles is important. The purpose is to prevent fixed contractures and reduce painful stiffness. Prolonged gentle stretch reduces overactive reflex loops in the muscles and makes walking more fluid. Monarch Initiative+1 -
Strength training with low resistance
Light resistance exercises for preserved muscles (such as hip and core muscles) can improve stability. The purpose is to strengthen areas that are still healthy without overworking already weak distal muscles. The mechanism is neuro-muscular adaptation: stronger proximal muscles compensate for distal weakness and help posture and gait. PMC+1 -
Balance and coordination training
Balance boards, tandem walking, and simple stability drills help the body adjust to reduced sensation in the feet. The purpose is to lower the risk of falls and boost confidence. Repeated practice improves the brain’s use of vision, inner-ear signals and remaining nerve input to stabilize the body. Cleveland Clinic+1 -
Aerobic exercise (walking, cycling, swimming)
Gentle cardio exercise improves heart health, mood and endurance. The purpose is to keep overall fitness high so everyday tasks feel easier. Mechanistically, aerobic activity improves blood flow to nerves and muscles and may reduce fatigue and deconditioning, as long as it is not pushed to pain or severe exhaustion. PMC+1 -
Hydrotherapy (water-based therapy)
Exercising in a warm pool supports body weight and makes movement easier. The purpose is to practice walking and strengthening with less joint load and less fear of falling. Buoyancy in water reduces stress on weak ankles and knees, while water resistance provides gentle, even strengthening. PMC -
Hand therapy and fine-motor training
Hand therapists use putty, small objects and task practice to maintain finger strength, dexterity and joint motion. The purpose is to keep writing, typing and self-care skills for as long as possible. The mechanism is targeted repetition that keeps neural pathways active and slows disuse atrophy of hand muscles. PMC+1 -
Splints for hands and thumbs
Soft or rigid splints can hold weak fingers or thumbs in functional positions. The purpose is to stabilize joints, prevent deformity and improve grip. Mechanically, splints redirect force through stronger joints and reduce strain on tiny, weak muscles. Mayo Clinic+2Cleveland Clinic+2 -
Posture and spine management
Because leg weakness and tone changes affect posture, therapists teach core strengthening, safe sitting and standing patterns, and sometimes use back braces. The purpose is to reduce back pain and prevent secondary spinal deformities. Better alignment spreads mechanical load more evenly through the spine and hips. Cleveland Clinic+1 -
Pain psychology and coping skills
Chronic nerve pain and disability can lead to anxiety, low mood and sleep problems. Psychological therapies, including cognitive behavioral therapy, help people understand pain, reduce fear and keep doing valued activities. The mechanism is changing how the brain interprets pain signals and building coping strategies, which can lower perceived pain and distress. PMC+1 -
Education about the disease and self-management
Clear teaching about hereditary motor and sensory neuropathy with pyramidal features helps patients and families understand what is happening and what is realistic. The purpose is to support informed decisions, safe activity and good long-term planning. Knowledge reduces fear and encourages early treatment of complications. AFM Téléthon+3Genetic and Rare Diseases Center+3NINDS+3 -
Genetic counselling for the family
A genetic counsellor explains the pattern of inheritance, testing options and family planning choices. The purpose is to help relatives understand their own risk and possible reproductive options. Mechanistically, this does not change the gene, but it can prevent surprises and support informed decisions about having children. MedlinePlus+2Genetic and Rare Diseases Center+2 -
Home safety and fall-prevention programs
Therapists may visit the home (or use photos and videos) to suggest grab bars, better lighting, removal of loose rugs and other safety changes. The purpose is to cut down fall risk. Changing the environment reduces the number of challenges that weak muscles and poor sensation must overcome. Cleveland Clinic+1 -
Lifestyle measures: sleep, stress and pacing
Good sleep, stress management and planned rest periods reduce fatigue, which can worsen weakness and pain. The purpose is to make daily life sustainable over years. The mechanism is to avoid “boom-and-bust” cycles, where doing too much in one day leads to several days of exhaustion and worse symptoms. Cleveland Clinic+2PMC+2 -
Community and peer support groups
Patient organizations for CMT connect people with the same condition. The purpose is emotional support, shared practical tips and access to research news. Support networks improve coping, reduce isolation and can increase adherence to therapies. AFM Téléthon+3Charcot-Marie-Tooth Association+3PMC+3 -
School and workplace accommodations
Adjusted schedules, ergonomic desks, permission to use mobility aids, and remote work or study options can be arranged. The purpose is to keep education and employment going as long as possible. The mechanism is social rather than biological: the environment is adapted so the person’s abilities are enough for the tasks they must do. PMC+1
Drug treatments
Important notes before the list:
-
There is no FDA-approved drug that cures hereditary motor and sensory neuropathy with pyramidal features. Current medicines are used to treat symptoms such as neuropathic pain, spasticity, mood problems and sleep, often based on evidence from other neuropathies (like diabetic neuropathy) and spasticity disorders. ScienceDirect+2PMC+2
-
Doses in real life must always be set by a neurologist or pain specialist, especially in children and teens. Never start, stop or change a dose on your own.
-
Below are examples of commonly used drugs with information based on FDA labels and clinical studies. They may or may not be suitable for a given patient.
-
Gabapentin
Gabapentin is an anti-seizure medicine widely used for neuropathic pain. In adults, doctors usually start with a low dose once at night and slowly increase to 3 times per day, adjusted for kidney function. The purpose is to reduce burning, shooting or electric pain. It binds to calcium channels in nerve cells and lowers abnormal pain signalling. Common side effects include sleepiness, dizziness and swelling. FDA Access Data+2FDA Access Data+2 -
Pregabalin (Lyrica)
Pregabalin is similar to gabapentin and is FDA-approved for several neuropathic pains, including diabetic neuropathy. Adults usually take it two or three times daily at doses chosen by their doctor. Its purpose is to calm nerve pain and sometimes improve sleep. It works by modulating calcium channels in over-active nerves. Common side effects are dizziness, weight gain and swelling of legs or hands. PMC+3FDA Access Data+3FDA Access Data+3 -
Duloxetine (Cymbalta)
Duloxetine is an antidepressant that is also approved for diabetic peripheral neuropathic pain and fibromyalgia. It is usually taken once daily in the morning or evening. The purpose is to reduce pain and at the same time improve mood and anxiety, which often accompany chronic illness. It increases serotonin and norepinephrine in the brain and spinal cord, which can dampen pain signals. Side effects may include nausea, dry mouth, sleep changes and sweating. PMC+3FDA Access Data+3FDA Access Data+3 -
Amitriptyline
Amitriptyline is a tricyclic antidepressant often used at low doses at night to help neuropathic pain and sleep. Doctors start with a very small dose and increase slowly to reduce side effects. Its purpose is to help with burning or tingling pain and improve sleep quality. It blocks re-uptake of serotonin and norepinephrine and also affects other receptors, which can dampen pain pathways but also cause dry mouth, constipation, weight gain and drowsiness. FDA Access Data+2FDA Access Data+2 -
Carbamazepine (Tegretol and related products)
Carbamazepine is an anti-seizure drug approved for trigeminal neuralgia pain and sometimes used for other nerve pains. The purpose is to reduce sharp, shock-like pain. It stabilizes hyper-excitable nerve cell membranes by blocking sodium channels. Doses are slowly increased while monitoring blood counts and liver tests because rare but serious side effects include low blood cells and liver problems, along with dizziness and nausea. FDA Access Data+2FDA Access Data+2 -
Topical lidocaine 5% patch (Lidoderm)
Lidocaine patches are placed on small areas of painful skin, such as areas of allodynia. The purpose is local pain relief without strong whole-body side effects. Lidocaine blocks sodium channels in small peripheral nerve endings, reducing their ability to fire pain signals. The patch is usually applied for limited hours per day on intact skin. Side effects are mainly local skin irritation or numbness. FDA Access Data+2FDA Access Data+2 -
Capsaicin 8% patch (Qutenza)
High-dose capsaicin patches are used in specialist clinics for certain peripheral neuropathic pains. The purpose is to give long-lasting relief to a very painful area by briefly overstimulating and then “desensitizing” pain fibres. The patch is applied for a short, controlled time and then removed; pain may flare during application, so local anaesthetic is often used. Side effects include burning and redness at the site. FDA Access Data+2FDA Access Data+2 -
Baclofen (oral)
Baclofen is a muscle relaxant used to treat spasticity in many neurological disorders. It is usually taken several times a day, starting with low doses and increasing under medical supervision. The purpose is to reduce muscle stiffness, cramps and spasms related to pyramidal tract involvement. It acts as a GABA-B receptor agonist in the spinal cord, decreasing excitatory signals to muscles. Side effects include sleepiness, weakness and, if stopped suddenly, risk of withdrawal symptoms. FDA Access Data+3FDA Access Data+3FDA Access Data+3 -
Tizanidine
Tizanidine is another short-acting drug for spasticity. It is taken several times per day with careful monitoring of blood pressure and liver function. The purpose is to ease stiffness and spasms that interfere with walking or using the hands. It works as an alpha-2 adrenergic agonist, reducing excitatory input to spinal motor neurons. Common side effects include drowsiness, low blood pressure and dry mouth. FDA Access Data+2FDA Access Data+2 -
Botulinum toxin type A (BOTOX) injections
In some patients with focal, very tight muscles, botulinum toxin injections can be used to reduce tone. A specialist injects small doses into selected muscles every few months. The purpose is to improve position of the foot or hand and reduce pain from severe spasticity. The toxin blocks acetylcholine release at the neuromuscular junction, weakening over-active muscles for a limited time. Side effects depend on dose and site and can include local weakness and, rarely, spread of effect. FDA Access Data+2FDA Access Data+2 -
Diazepam (Valium) – carefully, short term only
Diazepam is a benzodiazepine that can relax muscles and ease anxiety, but it carries high risks of dependence, sedation and breathing problems, especially when combined with other sedatives. In modern care it is usually reserved for short-term use when other options fail. It enhances GABA-A signalling in the brain, broadly calming neural activity. Side effects include sleepiness, confusion, falls and dependence, so it must be used with extreme caution or avoided. FDA Access Data+2FDA Access Data+2 -
Clonazepam (Klonopin) – selected situations
Clonazepam is another benzodiazepine used sometimes for myoclonus, tremor or severe night-time spasms. It is long-acting and can help sleep but shares the same dependency and sedation risks as diazepam. Doctors usually keep doses as low and short-term as possible. It potentiates GABA-A receptors and broadly quiets neuronal firing, which can reduce involuntary movements but also slow thinking and coordination. FDA Access Data+2FDA Access Data+2 -
Ibuprofen and other NSAIDs
Ibuprofen and naproxen are anti-inflammatory painkillers used for joint and muscle pains around weak ankles, knees and backs. They do not treat nerve damage, but they can help secondary musculoskeletal pain. They block cyclo-oxygenase enzymes and reduce prostaglandin-mediated inflammation. Side effects include stomach irritation, kidney strain and, with long-term use, increased cardiovascular risk, so doctors use the lowest effective dose and avoid them in some patients. FDA Access Data+5FDA Access Data+5FDA Access Data+5 -
Sertraline or other SSRIs
Living with a progressive, inherited disease can cause depression and anxiety. Sertraline is an SSRI antidepressant used once daily to improve mood and anxiety, which indirectly improves pain coping and function. It increases serotonin levels in brain synapses. Side effects can include nausea, sleep change and sexual dysfunction, and interactions with other medicines must be checked carefully. FDA Access Data+2FDA Access Data+2 -
Other symptom-focused medicines (examples only)
Depending on individual problems, doctors may consider medicines for bladder urgency, constipation, sleep, or blood pressure changes, always weighing benefits and risks. These drugs do not treat the underlying neuropathy but can significantly improve daily comfort and independence. The exact choice depends on age, other illnesses and current medicines, and must always be personalized. PMC+2Springer Link+2
(Many more medicines may be used in very specific situations, but the ones above are among the commonest in neuropathic and spasticity care. None should be started or changed without specialist advice, especially in teenagers.)
Dietary molecular supplements
Supplements can support general nerve health or treat specific deficiencies, but they are not magic cures. Some have modest evidence from peripheral neuropathy studies; others remain experimental. Doses and safety vary, so medical guidance is essential. PubMed+3PubMed+3PMC+3
-
Alpha-lipoic acid (ALA)
ALA is an antioxidant that has been studied mainly in diabetic neuropathy. Some trials show improved pain and nerve symptoms at daily doses around 600–1800 mg under medical supervision. The purpose is to reduce oxidative stress in nerves and possibly improve blood flow. Mechanistically, ALA scavenges free radicals and may help mitochondria work better. Side effects can include stomach upset and, rarely, low blood sugar in people with diabetes. American Academy of Neurology+3PubMed+3ClinicalTrials+3 -
Acetyl-L-carnitine (ALC)
ALC is involved in mitochondrial energy production and fatty-acid transport. Studies in different peripheral neuropathies suggest it may reduce pain and support nerve regeneration at doses often 1–3 g per day in divided doses in adults. The purpose is to support energy supply to damaged nerves. It likely works by improving mitochondrial function and possibly promoting nerve growth. Side effects can include nausea and, rarely, agitation. ClinicalTrials+3PMC+3PLOS+3 -
Vitamin B12 (cobalamin)
Vitamin B12 is essential for myelin and DNA synthesis. Deficiency can itself cause neuropathy and must be corrected with tablets or injections in medically supervised doses. In people with normal B12, very high extra doses have uncertain benefit. Mechanistically, B12 supports myelin repair and nerve regeneration and may reduce ectopic nerve firing. Side effects are usually mild, but high-dose products should not be taken without blood tests. Practical Neurology+3PubMed+3nhs.uk+3 -
Omega-3 fatty acids (EPA/DHA)
Omega-3s from fish oil or algae have anti-inflammatory and neuroprotective actions. Animal and small human studies suggest they may support nerve regeneration and reduce neuropathic pain, although human data are still limited and mixed. Typical supplemental doses are 1–3 g per day of combined EPA/DHA in adults. They change cell-membrane composition and reduce pro-inflammatory mediators. Side effects include fishy after-taste and, at high doses, a slight bleeding risk. Dove Medical Press+3PMC+3Frontiers+3 -
Vitamin D
Vitamin D supports bone health, muscle function and immune regulation. Low vitamin D is common in chronic illness and may worsen muscle weakness and pain. Supplement doses depend on blood levels and must be set by a doctor. The mechanism involves nuclear receptors in many tissues, including muscle and immune cells. Excessive intake can cause high calcium and kidney damage, so long-term high doses without monitoring are unsafe. nhs.uk+1 -
Coenzyme Q10 (CoQ10)
CoQ10 is part of the mitochondrial electron transport chain and acts as an antioxidant. In theory, it may help nerves by supporting energy production and reducing oxidative stress, but high-quality neuropathy trials are limited. Usual supplemental doses are 100–300 mg daily with food in adults. Side effects are usually mild stomach upset. It should not replace proven therapies. MDPI+1 -
Magnesium
Magnesium is important for nerve and muscle excitability. Correcting deficiency can help cramps and muscle irritability. Typical supplement doses vary by age and kidney function and must not exceed recommended safe limits. Mechanistically, magnesium modulates NMDA receptors and many enzyme reactions. Too much can cause diarrhea and, in kidney disease, dangerous high blood magnesium levels. nhs.uk+1 -
B-complex (especially avoiding excessive B6)
Balanced B-complex vitamins can support general nerve function when diet is poor, but high-dose vitamin B6 can actually damage nerves if used for long periods. Authorities have reported neuropathy cases from long-term high-dose B6 supplements, so any B-complex should stay within safe limits and be checked by a doctor. nhs.uk+2The Guardian+2 -
Curcumin (turmeric extract)
Curcumin has anti-inflammatory and antioxidant effects and is being studied in many chronic pain conditions. In theory it may reduce inflammatory aspects of neuropathic pain, but data are still preliminary. Typical supplements provide standardized extracts, often with piperine to improve absorption. Potential side effects include stomach upset and interactions with blood-thinning medicines. PMC+1 -
Probiotics and gut-health support
Gut–brain–nerve connections are complex, and probiotics are being studied in chronic pain and immune disorders. For hereditary neuropathy, evidence is indirect, but a healthy gut may support better overall health and treatment tolerance. Different products use different strains and doses, so guidance from a clinician is important, especially in immunocompromised people. nhs.uk+1
Immunity-boosting and regenerative / stem-cell-related drugs
For hereditary motor and sensory neuropathy with pyramidal features, there is currently no approved immune or stem cell drug that repairs the genes or fully regenerates nerves. The options below are mainly research directions; they are mentioned for understanding, not for self-treatment. Springer Link+3PMC+3ScienceDirect+3
-
Gene-therapy vectors targeted to CMT subtypes (research only)
For some CMT types, scientists are developing viral vectors (such as adeno-associated viruses) that carry healthy copies of genes or silence harmful ones. The purpose is to correct the underlying molecular defect in Schwann cells or axons. In models, these vectors can improve myelination and nerve conduction, but human trials are only beginning, and long-term safety is unknown. Pediatrics Nationwide+5PMC+5PMC+5 -
Mesenchymal stem cell (MSC) therapy
MSCs from bone marrow, umbilical cord or fat are being tested in peripheral neuropathy to see if they can release growth factors that support nerve repair. The purpose is to enhance regeneration and improve nerve conduction. Mechanisms include secretion of neurotrophic factors, immunomodulation and support of blood supply. Early trials show promise but also highlight many unknowns, so therapy should only occur inside regulated clinical trials. ScienceDirect+5PMC+5Frontiers+5 -
Induced pluripotent stem cell (iPSC)-based models
Researchers can reprogram a patient’s skin cells into iPSCs and then turn them into nerve or Schwann cells in the lab. The purpose is not direct treatment but to test drugs and gene therapies in a dish using the patient’s own mutation. This may lead to personalized therapies later. The mechanism is disease modelling and drug screening, not direct infusion into patients. Mayo Clinic+2AFM Téléthon+2 -
Immune-modulating therapies in overlapping conditions
In hereditary neuropathies that might also have inflammatory features, immune treatments like IVIG or steroids are sometimes studied, but they are not standard for pure HMSN with pyramidal signs. Their purpose is to calm autoimmune attacks on nerves where present. Because risks (infection, metabolic effects) are significant, these treatments are restricted to carefully selected cases. ScienceDirect+2PMC+2 -
Neurotrophic growth factor mimetics (experimental)
Compounds that mimic natural nerve growth factors are being tested in various neuropathies. The goal is to protect axons, support remyelination and prevent degeneration. Mechanisms include activation of survival pathways and stimulation of myelin-forming cells. As of now, no such drug is licensed for CMT, and use remains within trials. ScienceDirect+2ScienceDirect+2 -
Combined regenerative rehabilitation plus pharmacology
Many research programs study how best to combine potential regenerative drugs or biologics with intensive physical and occupational therapy. The idea is that if a drug improves nerve health even slightly, targeted exercise can help the nervous system “learn” to use the improved signals. This combined approach may become important if future disease-modifying therapies are approved. PMC+2PMC+2
Surgeries (Procedures and why they are done)
Surgery does not cure the neuropathy, but it can correct structural deformities and improve function or comfort in selected patients. Decisions are made by an orthopedic surgeon experienced in CMT, together with the rehab team. PMC+3NINDS+3Mayo Clinic+3
-
Foot and ankle deformity correction (osteotomy and fusion)
High-arched feet, clawed toes and ankle instability can be surgically corrected by cutting and realigning bones (osteotomy) and sometimes fusing joints. The procedure aims to create a flatter, more stable foot that fits better in shoes and braces. This can reduce pain, prevent ulcers and make walking safer. -
Tendon transfer surgery
In tendon transfers, a stronger muscle’s tendon is moved to take over a weak muscle’s function, such as helping lift the front of the foot in drop-foot. The purpose is to rebalance forces so the foot lands more normally. This can reduce tripping and may allow lighter braces. -
Achilles tendon lengthening
When calf muscles and Achilles tendon become too tight, the heel lifts early and walking becomes awkward. Lengthening the tendon surgically allows the heel to touch the ground better. The goal is to improve gait pattern, reduce pain and prevent long-term contracture. -
Spine surgery for severe scoliosis or kyphosis
If weakness and posture change lead to serious spinal curvature that affects breathing or causes severe pain, spinal fusion surgery may be offered. The purpose is to stabilize the spine, prevent further deformity and protect lung function. This is major surgery and only considered when conservative care is not enough. -
Nerve decompression in selected cases
Some patients may develop compression of already fragile nerves at common places like the ankle or wrist. Surgical decompression releases tight tunnels around these nerves. The aim is to prevent extra injury and possibly relieve pain or numbness. Benefits must be weighed carefully because underlying hereditary damage remains.
Prevention and long-term self-care
You cannot yet prevent the underlying gene change, but you can lower the risk of complications and disability: nhs.uk+3NINDS+3Cleveland Clinic+3
-
Keep regular appointments with a neurologist and rehab team.
-
Start physical and occupational therapy early, not only when disability is severe.
-
Use prescribed braces and walking aids consistently to avoid falls.
-
Protect your feet: daily skin checks, well-fitting shoes, and prompt treatment of any blisters or sores.
-
Avoid medicines known to be toxic to peripheral nerves when alternatives exist (your doctor will advise).
-
Maintain a healthy weight to lower strain on weak joints and muscles.
-
Do not smoke and keep alcohol within medical advice, as both can worsen nerve damage.
-
Stay up to date with vaccinations (especially flu, COVID-19 and pneumonia as advised) to reduce infection stress on the body.
-
Plan safe activity levels: regular gentle exercise, but stop before severe fatigue or pain.
-
Seek help early for mood changes, pain flares or new symptoms instead of waiting until they are severe.
When to see doctors
You should see a doctor – ideally a neurologist experienced in neuromuscular disease – if you: PMC+3Genetic and Rare Diseases Center+3NINDS+3
-
Notice slowly progressive weakness in the feet, legs, hands or arms, especially with family history of similar problems.
-
Develop frequent tripping, foot drop, high arches or claw toes.
-
Have new or worsening burning, tingling, electric shocks or cramps in your limbs.
-
See signs of spasticity such as stiff legs, very brisk reflexes or toes that go up (Babinski sign).
-
Get new bladder, bowel or swallowing problems.
-
Notice skin ulcers, colour changes or infections on your feet or hands.
-
Experience strong mood changes, anxiety or sleep problems related to the disease.
-
Plan pregnancy or need guidance for family-planning and genetic testing.
Emergency care is needed if you have sudden severe weakness, difficulty breathing, high fever with rapidly worsening symptoms, or thoughts of serious self-harm or harm to others.
What to eat and what to avoid
Diet cannot change the gene, but it can support your muscles, nerves, bones and overall health. The Guardian+3nhs.uk+3Cleveland Clinic+3
-
Eat: a balanced diet rich in vegetables, fruits, whole grains, legumes and nuts to supply antioxidants, fibre and micronutrients.
-
Eat: adequate protein from fish, eggs, dairy, poultry or plant sources to support muscles and healing.
-
Eat: sources of healthy fats such as oily fish (if allowed), flaxseed and walnuts for omega-3s.
-
Eat: foods containing B vitamins (whole grains, eggs, dairy, meat or fortified foods) to support nerve health when possible.
-
Eat: calcium and vitamin-D-rich foods (dairy, fortified drinks, small fish with bones, leafy greens) to protect bones weakened by low activity.
-
Avoid: very high-dose over-the-counter vitamin supplements, especially B6, without medical advice, because they can themselves harm nerves. The Guardian+1
-
Avoid: excessive sugary drinks and ultra-processed foods that promote weight gain and inflammation.
-
Avoid: heavy alcohol use, which can damage nerves and worsen balance.
-
Avoid: crash diets or extreme fasting, which may cause muscle loss and vitamin deficiencies.
-
Be cautious with herbal products advertised as “nerve cures” or “stem cell in a bottle”; these are not proven, may interact with medicines and can be unsafe. PMC+2MDPI+2
A registered dietitian working with your neurologist can customize a plan if you have other conditions, such as diabetes or kidney disease.
Frequently asked questions (FAQs)
-
Is hereditary motor and sensory neuropathy with pyramidal features curable?
At the moment there is no cure and no approved drug that stops the genetic process. Treatment focuses on keeping you mobile, independent and as pain-free as possible through rehabilitation, symptom medicines and, in some cases, surgery. Springer Link+3Genetic and Rare Diseases Center+3Wikipedia+3 -
Will I definitely end up in a wheelchair?
Many people with this condition walk for decades, especially with early braces, therapy and foot care. Some may use a wheelchair or scooter for long distances to save energy and prevent falls, but that is part of smart energy management, not “failure.” Charcot-Marie-Tooth Association+3Cleveland Clinic+3PMC+3 -
Does exercise make the disease worse?
Gentle, regular exercise is usually helpful, not harmful, as long as it is guided by a therapist and does not cause strong pain or long-lasting fatigue. Over-training can strain weak muscles and joints, so the key rule is “little and often,” not “no pain, no gain.” PMC+2Charcot-Marie-Tooth Association+2 -
Is this the same as multiple sclerosis (MS)?
No. Both involve the nervous system, but hereditary motor and sensory neuropathy with pyramidal features mainly affects peripheral nerves and is genetic, while MS is an autoimmune disease affecting the brain and spinal cord. Their treatments and prognosis are different. Wikipedia+2MedlinePlus+2 -
Can children or teenagers have this condition?
Yes. Symptoms often start in childhood, teen years or young adulthood, though some people only notice problems later. Early diagnosis allows earlier physiotherapy, bracing and school supports, which can greatly help long-term function. Cleveland Clinic+3Genetic and Rare Diseases Center+3Mayo Clinic+3 -
Will all my children get the disease?
Risk depends on the exact gene and inheritance pattern (autosomal dominant, recessive, or X-linked). Some children may inherit the mutation, some may not. A genetic counsellor can estimate your personal risk and discuss testing options. AFM Téléthon+3MedlinePlus+3Genetic and Rare Diseases Center+3 -
Does this condition shorten life expectancy?
For many people, hereditary motor and sensory neuropathy mainly affects quality of life, not lifespan, especially with good medical care, fall prevention and infection control. Severe complications (for example, major falls or untreated infections) can be dangerous, so proactive care is important. Genetic and Rare Diseases Center+2Cleveland Clinic+2 -
Is nerve pain “in my head”?
Neuropathic pain is very real. It comes from damaged or over-excited nerves sending incorrect signals. Medicines, psychological therapies and lifestyle steps can all help reduce how strongly the pain is felt, but the pain is not imagined or fake. MDPI+3PubMed+3PubMed+3 -
Can I still play sports?
Many people can enjoy low-impact sports such as swimming, cycling or yoga, especially when supervised by a therapist. High-risk activities with jumping, twisting or contact may be unsafe. A good rule is to choose sports that feel stable and do not cause injuries or big flares the next day. Cleveland Clinic+2PMC+2 -
Will gene therapy be available soon?
Gene therapy research for CMT is moving quickly and early studies in animals look promising, but human trials are still in early or planning phases. It is too soon to promise when or whether a safe, effective gene therapy will be widely available. Taylor & Francis Online+4PMC+4PMC+4 -
Can stem-cell clinics cure my neuropathy now?
Many commercial clinics advertise stem-cell cures, but most operate outside strong scientific and regulatory control. Current high-quality evidence supports stem cells mainly as an experimental treatment in tightly controlled trials, not routine care. You should be extremely cautious about expensive, unregulated “cures.” Springer Link+4PMC+4Frontiers+4 -
Is pregnancy safe if I have this condition?
Many people with CMT have successful pregnancies. However, increased weight and balance changes can make walking harder and increase fall risk. Genetic counselling is important to discuss inheritance, and obstetric and neurology teams should plan care together. AFM Téléthon+3Genetic and Rare Diseases Center+3Cleveland Clinic+3 -
Can the disease affect my thinking or memory?
Hereditary motor and sensory neuropathy with pyramidal features mainly affects peripheral nerves and motor pathways; thinking and memory are usually normal. Mood, fatigue and pain, however, can make concentration harder, so mental health support is still important. Genetic and Rare Diseases Center+2MalaCards+2 -
How often should I have follow-up visits?
Many specialists recommend at least yearly review, and more often during periods of change, such as rapid symptom progression, new braces or after surgery. Regular check-ups allow early adjustment of therapy, braces and medicines before problems become severe. Cleveland Clinic+2PMC+2 -
What is the most important thing I can do today?
The single most powerful step is to build a long-term partnership with your care team: neurologist, rehab therapists, orthotist, mental-health professional and, when needed, orthopedic surgeon. Following a personalized plan for exercise, braces, pain control, foot care and mental health can greatly improve comfort and independence, even though the underlying gene change is still there. AFM Téléthon+3PMC+3Cleveland Clinic+3
Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.
The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members
Last Updated: December 31, 2025.